Shanghai MicroPort Endovascular MedTech Co., Ltd.

Equities

688016

CNE100003MJ5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 18:00:00 2024-07-16 EDT 5-day change 1st Jan Change
95.35 CNY +2.52% Intraday chart for Shanghai MicroPort Endovascular MedTech Co., Ltd. -7.05% -27.00%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
MicroPort Endovascular MedTech Gets Registration Approval for Filter Recovery Device MT
MicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue MT
MicroPort Endovascular Expects Up to 30% Profit Growth in H1; Shares Rise 6% MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2024 CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
MicroPort Scientific Unit to See Up to 38% Boost in 2023 Profit MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023 CI
EV MedTech Raises 1.8 Billion Yuan from Placement MT
MicroPort Endovascular MedTech Elects Chairman MT
Shanghai MicroPort Endovascular MedTech's Profit Up 29% in Q1-Q3 MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shanghai MicroPort Endovascular MedTech's H1 Attributable Profit Increases 30% MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Bourse Approves EV MedTech's Proposed Share Issuance MT
EV MedTech Expects Up to 30% Increase in First-Half Profit MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2022 CI
Shanghai Hongmai Medical Technology Co., Ltd. announced that it expects to receive CNY 45 million in funding from Shanghai MicroPort Endovascular MedTech Co., Ltd., Shanghai Xiying Enterprise Consulting Partnership (Limited Partnership) CI
Shanghai MicroPort Endovascular MedTech Co., Ltd.(SHSE:688016) dropped from Shanghai Stock Exchange Health Care Sector Index CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shanghai MicroPort Endovascular MedTech Sees Q3 Profit Jump 31.5% MT
Shanghai MicroPort Endovascular MedTech Co., Ltd.(XSSC:688016) added to S&P Global BMI Index CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chart Shanghai MicroPort Endovascular MedTech Co., Ltd.
More charts
Shanghai MicroPort Endovascular MedTech Group Co Ltd, formerly Shanghai MicroPort Endovascular MedTech Co Ltd, is a China-based company principally engaged in the research and development, production and sales of aortic and peripheral vascular interventional medical devices. The Company's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral vascular stent system and peripheral balloon dilatation catheters for the treatment of peripheral vascular diseases. The Company mainly distributes its products to the domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
95.35 CNY
Average target price
162.8 CNY
Spread / Average Target
+70.73%
Consensus
  1. Stock Market
  2. Equities
  3. 688016 Stock
  4. News Shanghai MicroPort Endovascular MedTech Co., Ltd.
  5. MicroPort Endovascular MedTech Gets Registration Approval for Filter Recovery Device